Wuhan Hvsen Biotechnology Co., Ltd. (hereinafter referred to as "HVSEN BIOTECH") was established in 2002 with a registered capital of 166 million Yuan. It is a national high-tech enterprise focusing on the field of animal health. On 24 August 2020, HVSEN BIOTECH was officially listed on gem of Shenzhen Stock Exchange (stock code: 300871). According to the Veterinary Drug Industry Development Report (2020 year) released by China Veterinary Drug Association, HVSEN BIOTECH sales ranked top 5 in the field of veterinary preparations in China.
At present, HVSEN BIOTECH has been accepted 74 patent applications, 48 patents have been authorized, and 11 national new veterinary drug certificates hav...
